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Abstract 
Purpose: To explore the effect of Radix Bupleuri extract (RBE) on diethylnitrosamine (DEN)-induced 
liver cirrhosis in rats. 
Methods: Rats were injected with DEN once a week for 8 weeks to induce liver cirrhosis. Some DEN-
induced rats were also treated with RBE, which was obtained by extracting dried Radix Bupleuri in 
water, for 8 weeks. Afterwards, biochemical indices and oxidative stress markers were assessed. 
Results: RBE significantly decreased serum concentrations of both alanine transaminase (137.3 ± 4.4 
U/L, p < 0.01) and aspartate aminotransaminase (152.1 ± 3.4 U/L, p < 0.01) in DEN-induced rats at 
week 8. In addition, RBE significantly decreased malondialdehyde (0.13 ± 0.02 umol/L, p < 0.01) and 
superoxide dismutase (0.73 ± 0.04 U/mg protein, p < 0.01) levels in DEN-induced rats (p < 0.01).  
Conclusion: RBE exhibits a protective effect against DEN-induced liver cirrhosis in rats. Thus, it may 
have the potential to be used to treat liver cirrhosis in clinical settings.  
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Liver fibrosis is a multi-step process that results 
from various factors, such as viral hepatitis, 
alcohol abuse, biliary atresia, and hepatotoxins. 
Liver cirrhosis is the end stage of this reaction. In 
general, liver fibrosis is reversible and is 
associated with the apoptosis of activated 
hepatic stellate cells [1]. The characteristics of 
liver cirrhosis include cell viability and a decrease 
in redox ratios, along with reactive oxygen 
species formation, lipid peroxidation, DNA 
fragmentation, and apoptotic body formation. All 
of these factors are potential targets for therapy 
[2]. The inhibition of oxidative stress has been 
shown to play an important role in preventing the 
progression of liver cirrhosis [3]. In addition, the 
degree of liver cirrhosis observed in humans is 
similar to that observed in diethylnitrosamine 
(DEN)-induced rats [4,5]. 
 
Pharmacological experiments have 
demonstrated that Radix Bupleuri possesses 
wide-reaching biological activities, including 
coronary artery dilation, immune system 
modulation, anti-inflammatory properties and 
analgesia [6-11]. Due to the traditional use of 
Radix Bupleuri in the prevention of liver cirrhosis 
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[12], this study was performed to investigate the 
protective effect of Radix Bupleuri extract (RBE) 






Herbal samples of Radix Bupleuri were collected 
from Bozhou City, Anhui Province (China), in 
May 2015. Taxonomic identification of the plant 
was performed by Professor Hui Chu (College of 
Pharmacy, Wuhan University, China). A voucher 
specimen (no. RB 201505016) was deposited in 
the College of Pharmacy (Wuhan University, 
China) herbarium. RBE was obtained by 
steeping dried Radix Bupleuri in water at 60 °C 
for 1 h and then drying it in an oven. This 
process was performed three times. Finally, the 
extract was freeze-dried. One gram of extract 
powder was equivalent to about 2.0 g of crude 
plant material, i.e., a yield of 50.0 %. 
 
Preparation of animal models and groups 
 
Male Wistar rats weighing 180 – 220 g were 
provided by the Experimental Animal Center of 
Hubei Province (Certificate no. SYXK 2007-
0006). The rats had free access to feed and 
water and were allowed to acclimate for at least 
1 week before use. Animal experiments were 
approved by the Animal Care and Use 
Committee of Wuhan University (approval ref no. 
20110908) and were performed in compliance 
with Directive 2010/63/EU on the handling of 
animals used for scientific purposes [13]. 
 
To generate liver cirrhosis model rats, rats were 
injected with DEN (70 mg/kg body weight/rat) 
once a week for 8 weeks. Rats were randomly 
divided into 3 groups containing 10 rats each. 
Group I consisted of normal rats that were 
treated with oral saline solution for 8 weeks 
(normal group). Group II consisted of liver 
cirrhosis model rats that were treated with oral 
saline solution for 8 weeks (model group). Group 
III consisted of liver cirrhosis model rats that 
were treated with oral RBE (40 mg/kg body 
weight/rat, once daily) for 8 weeks (RBE group). 
 
Determination of biochemical indices 
 
In weeks 4 and 8, blood samples (0.5 mL) were 
collected by puncturing the retro-orbital sinus. 
Serum was obtained by immediately centrifuging 
blood samples at 3,500 g for 15 min. Serum 
levels of alanine transaminase (ALT) and 
aspartate aminotransaminase (AST) were 
measured spectrophotometrically, using 
commercially available kits (Nanjing Jiancheng 
Bioengineering Institute). 
 
Determination of oxidative stress parameters 
in liver tissues 
 
Rats were sacrificed by cervical dislocation, after 
which the livers were excised, rapidly washed, 
and homogenized in ten volumes (v/w) of ice-
cold saline solution. The homogenate was 
centrifuged at 3,000 rpm for 10 min.  
 
Levels of malondialdehyde (MDA), a biomarker 
of lipid peroxidation, were determined 
spectrophotometrically by measuring 
thiobarbituric acid reactive substances (TBARS). 
Trichloroacetic acid (10 % solution, 1 mL) and 1 
mL of 0.67 % thiobarbituric acid were added to 
0.2 mL of the 10 % homogenates of the tissue 
samples. The mixtures were incubated at 100 °C 
for 15 min. After cooling and centrifuging, the 
supernatant was aspirated, and its absorbance 
determined at 532 and 600 nm. The 
concentration of MDA (μmol/L) was calculated 
according to Eq 1. 
 
MDA = 6.45(A532 – A600) ……..…………….. (1) 
 
Where A532 – A600 are the absorbance at 532 and 
600 nm, respectively.  
 
Superoxide dismutase (SOD) activity was 
measured spectrophotometrically using 
commercially available SOD kits (A001-1 




Data are presented as mean ± standard 
deviation (SD) and were analyzed by one-way 
ANOVA, followed by Tukey’s multiple 
comparison, using SPSS 16.0 software for 
Windows. Differences were considered 




Induction of fibrosis and cirrhosis 
 
During the weekly DEN injections, the body 
weights dropped gradually. After 4 weeks of 
weekly DEN injections, marked increases in the 
activity of serum ALT and AST (p < 0.01) were 
observed. RBE ameliorated the increase in ALT 
and AST levels. After the eighth week of DEN 
injections, liver cirrhosis was induced. Serum 
concentrations of ALT and AST after 8 weeks of 
DEN injections were significantly lower than 
those after 4 weeks of DEN injections (p < 0.05) 
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but were still higher than those in the normal 
group. Compared with the model group, plasma 
concentrations of both ALT and AST in RBE 
group decreased significantly (p < 0.01) at 8 
weeks (Tables 1 and 2). 
 
Table 1: Serum alanine transaminase (U/L) at 
different time points  
 
Group 0 week 4 weeks 8 weeks 
Normal 101.3±3.4 99.26±3.6 100.6±3.5 
Model 102.5±3.3  523.1±12.4**  238.4±9.6* 
RBE 102.8±3.4 152.6±5.7△△ 137.3±4.4△△ 
*P < 0.05; **p < 0.01 vs. normal group; △p < 0.05; △△p < 
0.01 vs. control group 
 
Table 2: Serum aspartate aminotransaminase (U/L) at 
different time points 
 
Group 0 week 4 weeks 8 weeks 
Normal 108.6±4.2 104.4±3.8 106.1±3.2 
Model 106.4±4.5  347.6±10.4** 198.5±5.3* 
RBE 101.5±4.7 134.7±6.2△△ 152.1±3.4△△ 
*P < 0.05; **p < 0.01 vs. normal group; △p < 0.05; △△p < 
0.01 vs. control group 
 
Table 3: Malondialdehyde (MDA) and superoxide 
dismutase (SOD) levels in rat liver 
 
Group MDA (µmol/L) SOD (U/mg protein) 
Normal 0.08±0.03      0.82±0.12 
Model   0.32±0.02** 0.46±0.06** 
RBE   0.13±0.02** 0.73±0.04** 
*P < 0.05，** p < 0.01 vs. control group 
 
Effect of RBE on MDA and SOD levels 
 
MDA levels were significantly increased in DEN-
induced rats (p < 0.01), as compared with rats in 
the normal group. RBE significantly inhibited 
MDA formation in DEN-induced livers (p < 0.01). 
Conversely, RBE significantly increased levels of 




Recently, many researchers have focused on the 
anti-fibrotic properties of herbal medicines. We 
show that the oral administration of RBE exerted 
a protective effect on DEN-induced liver fibrosis 
and cirrhosis. Several mechanisms that may 
participate in the induction of the fibrotic process 
include the inhibition of necrosis and apoptosis 
[14], the prevention of inflammation, and the 
activation of hepatic stellate cells [15]. 
 
Levels of MDA, which is an end product of lipid 
peroxidation [16], were significantly increased in 
DEN-induced rats. RBE remarkably inhibited 
MDA formation and increased the activity of SOD 
in DEN-induced rats. Thereby, RBE acted as an 
anti-oxidant to inhibit the process of DEN-
induced fibrosis. Furthermore, RBE reduced 
serum levels of ALT and AST at weeks 4 and 8, 
as compared with saline-treated, DEN-induced 
rats. These findings demonstrate that RBE 
played a role in the attenuation of apoptosis and 
oxidative stress in the fibrotic liver. Therefore, 
RBE may be used as a potential anti-fibrotic 
agent in the future. 
 
In the present study, RBE was effective in the 
treatment of chemically induced liver fibrosis in 
rats. Its anti-fibrotic mechanisms involve the 
inhibition of oxidative stress, apoptosis, and 





RBE shows protective effect against DEN-
induced liver cirrhosis in rats and thus, can 
potentially be used for the treatment of liver 




Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by them. Wan-he Tang and 
Quan-wei Yang contributed equally to this work. 
 
Open Access  
 
This is an Open Access article that uses a 
funding model which does not charge readers or 
their institutions for access and distributed under 
the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by 
/4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/rea
d), which permit unrestricted use, distribution, 
and reproduction in any medium, provided the 




1. Tang X, Yang J, Li J. Accelerative effect of leflunomide 
on recovery from hepatic fibrosis involves TRAIL-
mediated hepatic stellate cell apoptosis. Life Sci 2009; 
84: 552–557. 
Tang et al 
Trop J Pharm Res, December 2016; 15(12): 2632  
 
2. Lakshmi DS, Anuradha CV. Mitochondrial damage, 
cytotoxicity and apoptosis in iron-potentiated alcoholic 
liver fibrosis: amelioration by taurine. Amino Acids 2010; 
38: 869-879. 
3. Lv P, Luo HS, Zhou XP, et al. Thalidomide prevents rat 
liver cirrhosis via inhibition of oxidative stress. Pathol. 
Res. Pract. 2006; 202: 777-788. 
4. Gang Z, Qi Q, Jing C, Wang C. Measuring 
microenvironment mechanical stress of rat liver during 
diethylnitrosamine induced hepatocarcinogenesis by 
atomic force microscope. Microsc. Res. Tech. 2009; 72: 
672–678. 
5. Jin N, Deng J, Chadashvili T. Carbogen gas-challenge 
BOLD MR imaging in a rat model of diethylnitrosamine-
induced liver fibrosis. Radiology 2010; 254: 129-137. 
6. Xiao PG. Modern Chinese Material Medica, Vol 2. 
Beijing: Chemical Industrial Press: 2002. 184 p. 
7. Cheng JX, Zhu ZJ, Liang G, et al. The effects of Ligusticu 
Chuanxiong Hort and Radix Bupleuri on the immune 
system in rats. Pract. Clin. J. Integr. Tradit. Chin. West. 
Med. 1994; 7: 261–262. 
8. Li YH, Wang NS. Antithrombotic effects of Danggui, 
Chaihu and potential drug interaction with clopidogrel. J 
Ethnopharmacol. 2010; 128: 623–628. 
9. Wang Y, Chen P, Tang CY ,et al. Antinociceptive and 
anti-inflammatory activities of extract and two isolated 
flavonoids of Radix Bupleuri. J Ethnopharmacol 2012; 
151: 944-950. 
10. Wang CC, Choy CS, Liu YH. Protective effect of dried 
Radix Bupleuri aqueous extract and its main constituent, 
carthamus yellow, against lipopolysaccharide-induced 
inflammation in RAW 264.7 macrophages. J. Sci. Food 
Agric. 2011; 91: 218–225. 
11. Hiramatsu M, Takahashi T, Komatsu M. Antioxidant and 
neuroprotective activities of Mogami-benibana 
(Safflower, Carthamus tinctorius Linne). Neurochem. 
Res. 2009; 34: 795–805. 
12. Zou TY. Clinical study of Radix Bupleuri injection 
combined with Astragalus injection treatment in patients 
with decompensated cirrhosis. Chi J ethnomedicine and 
Ethnopharmacy. 2008; 10: 45-47. 
13. European Commission [homepage on the internet]. 
Directive 2010/63/EU on the protection of animals used 
for scientific purposes [cited 2013 Jan 16]. Available 
from:http://ec.europa.eu/environment/chemicals/lab_ani
mals/legislation_en.htm.  
14. Lu B, Xu Y, Xu L. Mechanism investigation of dioscin 
against CCl4-induced acute liver damage in mice. 
Environ. Toxicol. Pharmacol. 2012; 34: 127–135. 
15. Friedman SL. Mechanisms of disease: mechanisms of 
hepatic fibrosis and therapeutic implications. Nat. Clin. 
Pract. 2004; 1: 98–105. 
16. Tan Y, Yin P, Tang L. Metabolomics study of stepwise 
hepatocarcinogenesis from the model rats to patients: 
potential biomarkers effective for small hepatocellular 
carcinoma diagnosis. Mol. Cell. Proteomics 2012; 11: 
257-259. 
 
